Regulus Therapeutics Inc. announced the resignation of Dr. Timothy Wright, Chief Research and Development Officer, effective March 15, 2019. Dr. Wright is leaving for personal reasons to pursue a new opportunity, and will continue to support Regulus as a scientific advisor. Tim's role as a scientific advisor to the company will enable a smooth transition and support interactions with FDA regarding RGLS4326.